Lexagene Holdings (Lexagene Holdings) Debt-to-EBITDA : -0.29 (As of Nov. 2022)

Lexagene Holdings Debt-to-EBITDA Chart

Lexagene Holdings Annual Data
	Trend	Mar13	Mar14	Mar15	Feb16	Feb17	Feb18	Feb19	Feb20	Feb21	Feb22
Debt-to-EBITDA		Get a 7-Day Free Trial					-	-	-0.28	-0.17	-0.12

Lexagene Holdings Quarterly Data
	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22
Debt-to-EBITDA	Get a 7-Day Free Trial															-0.12	-0.15	-0.15	-0.13	-0.29

Competitive Comparison of Lexagene Holdings's Debt-to-EBITDA

For the Medical Devices subindustry, Lexagene Holdings's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lexagene Holdings's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lexagene Holdings's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Lexagene Holdings's Debt-to-EBITDA falls into.

Lexagene Holdings Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Lexagene Holdings's Debt-to-EBITDA for the fiscal year that ended in Feb. 2022 is calculated as

Lexagene Holdings's annualized Debt-to-EBITDA for the quarter that ended in Nov. 2022 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Nov. 2022) EBITDA data.

Lexagene Holdings  (OTCPK:LXXGQ) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Lexagene Holdings Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Lexagene Holdings's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Lexagene Holdings (Lexagene Holdings) Business Description